CorMedix
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $101,931 | $127,427 | $128,615 | $104,275 |
Gross Profit | 77,126 | 105,122 | 107,308 | 93,080 |
EBITDA | 57,387 | 66,189 | 68,697 | 57,314 |
EBIT | 47,087 | 55,645 | 58,263 | 53,524 |
Net Income | 25,988 | 38,601 | 14,020 | 108,562 |
Net Change In Cash | 101,931 | 127,427 | 128,615 | 104,275 |
Free Cash Flow | 86,966 | 41,653 | 92,741 | 30,350 |
Cash | 256,692 | 178,087 | 145,825 | 48,493 |
Basic Shares | 92,479 | 92,985 | 93,919 | 86,214 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $311,709 | $43,472 | $0 | $65 |
Gross Profit | 275,748 | 40,281 | -205 | 61 |
EBITDA | 167,785 | -18,978 | -46,234 | -30,051 |
EBIT | 152,798 | -19,288 | -46,304 | -30,260 |
Net Income | 163,055 | -17,930 | -46,339 | -29,701 |
Net Change In Cash | 311,709 | 43,472 | 0 | 65 |
Free Cash Flow | 172,786 | -50,731 | -38,736 | -24,576 |
Cash | 145,825 | 40,650 | 43,642 | 43,374 |
Basic Shares | 80,308 | 58,871 | 50,902 | 40,274 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.29 |
2026-03-31 | $0.35 |
2025-12-31 | $0.16 |
2025-09-30 | $1.41 |